Compare Wockhardt with JUBILANT LIFE SCIENCES - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs JUBILANT LIFE SCIENCES - Comparison Results

WOCKHARDT     Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT JUBILANT LIFE SCIENCES WOCKHARDT/
JUBILANT LIFE SCIENCES
 
P/E (TTM) x -47.0 12.0 - View Chart
P/BV x 1.0 2.2 46.6% View Chart
Dividend Yield % 0.0 0.7 0.6%  

Financials

 WOCKHARDT   JUBILANT LIFE SCIENCES
EQUITY SHARE DATA
    WOCKHARDT
Mar-18
JUBILANT LIFE SCIENCES
Mar-19
WOCKHARDT/
JUBILANT LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs1,012898 112.7%   
Low Rs532618 86.1%   
Sales per share (Unadj.) Rs355.9572.0 62.2%  
Earnings per share (Unadj.) Rs-60.336.2 -166.4%  
Cash flow per share (Unadj.) Rs-46.859.5 -78.6%  
Dividends per share (Unadj.) Rs0.014.50 0.2%  
Dividend yield (eoy) %00.6 0.2%  
Book value per share (Unadj.) Rs257.8301.9 85.4%  
Shares outstanding (eoy) m110.63159.28 69.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.21.3 163.7%   
Avg P/E ratio x-12.820.9 -61.2%  
P/CF ratio (eoy) x-16.512.7 -129.6%  
Price / Book Value ratio x3.02.5 119.3%  
Dividend payout %012.4 -0.1%   
Avg Mkt Cap Rs m85,379120,694 70.7%   
No. of employees `0006.32.4 261.7%   
Total wages/salary Rs m9,37119,260 48.7%   
Avg. sales/employee Rs Th6,295.038,120.6 16.5%   
Avg. wages/employee Rs Th1,498.38,058.4 18.6%   
Avg. net profit/employee Rs Th-1,066.32,414.3 -44.2%   
INCOME DATA
Net Sales Rs m39,36991,108 43.2%  
Other income Rs m1,202357 336.4%   
Total revenues Rs m40,57191,466 44.4%   
Gross profit Rs m1817,390 0.1%  
Depreciation Rs m1,4953,709 40.3%   
Interest Rs m2,5552,198 116.2%   
Profit before tax Rs m-2,83011,840 -23.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-3,582-2,802 127.8%   
Tax Rs m2573,268 7.9%   
Profit after tax Rs m-6,6695,770 -115.6%  
Gross profit margin %019.1 0.2%  
Effective tax rate %-9.127.6 -32.9%   
Net profit margin %-16.96.3 -267.5%  
BALANCE SHEET DATA
Current assets Rs m33,79645,848 73.7%   
Current liabilities Rs m26,91720,897 128.8%   
Net working cap to sales %17.527.4 63.8%  
Current ratio x1.32.2 57.2%  
Inventory Days Days7957 139.7%  
Debtors Days Days8951 175.2%  
Net fixed assets Rs m39,66465,498 60.6%   
Share capital Rs m553159 347.3%   
"Free" reserves Rs m27,96847,930 58.4%   
Net worth Rs m28,52248,089 59.3%   
Long term debt Rs m21,73142,429 51.2%   
Total assets Rs m81,620114,685 71.2%  
Interest coverage x-0.16.4 -1.7%   
Debt to equity ratio x0.80.9 86.4%  
Sales to assets ratio x0.50.8 60.7%   
Return on assets %-5.06.9 -72.5%  
Return on equity %-23.412.0 -194.9%  
Return on capital %-7.712.4 -61.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m9,80712,422 78.9%   
Fx outflow Rs m1,78917,227 10.4%   
Net fx Rs m8,019-4,805 -166.9%   
CASH FLOW
From Operations Rs m68411,215 6.1%  
From Investments Rs m6,302-10,118 -62.3%  
From Financial Activity Rs m-7,6956,574 -117.0%  
Net Cashflow Rs m-6647,612 -8.7%  

Share Holding

Indian Promoters % 74.5 45.6 163.4%  
Foreign collaborators % 0.0 3.5 -  
Indian inst/Mut Fund % 2.3 8.7 26.4%  
FIIs % 7.7 21.2 36.3%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 21.1 73.0%  
Shareholders   67,757 23,815 284.5%  
Pledged promoter(s) holding % 0.0 15.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT With:   TORRENT PHARMA  ALEMBIC PHARMA  ELDER PHARMA  SANOFI INDIA  DR. DATSONS LABS  

Compare WOCKHARDT With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Continue Momentum; Sensex Ends 187 Points Higher(Closing)

Indian share markets end on a positive note with the Sensex up by 187 points, while the Nifty closed up by 36 points.

Related Views on News

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY20); Net Profit Up 358.8% (Quarterly Result Update)

Jun 1, 2020 | Updated on Jun 1, 2020

For the quarter ended March 2020, JUBILANT LIFE SCIENCES has posted a net profit of Rs 3 bn (up 358.8% YoY). Sales on the other hand came in at Rs 24 bn (up 0.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (3QFY20); Net Profit Down 24.0% (Quarterly Result Update)

Feb 1, 2020 | Updated on Feb 1, 2020

For the quarter ended December 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (down 24.0% YoY). Sales on the other hand came in at Rs 23 bn (down 2.6% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

WOCKHARDT Announces Quarterly Results (3QFY20); Net Profit Up 125.0% (Quarterly Result Update)

Jan 28, 2020 | Updated on Jan 28, 2020

For the quarter ended December 2019, WOCKHARDT has posted a net profit of Rs 192 m (up 125.0% YoY). Sales on the other hand came in at Rs 9 bn (down 16.9% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (2QFY20); Net Profit Up 18.9% (Quarterly Result Update)

Oct 31, 2019 | Updated on Oct 31, 2019

For the quarter ended September 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 18.9% YoY). Sales on the other hand came in at Rs 23 bn (down 0.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Sep 5, 2019 | Updated on Sep 5, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1(Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Be Prepared to Profit from the Coming Crash in Oil Prices(Fast Profits Daily)

Jun 25, 2020

The stability in crude oil prices will not last much longer. Be ready to make fast profits when the time comes to short crude.

Two Agri Stocks Are Likely to Outperform Even in this Market(Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

Tata Motors Tripled in 18 Months but You Can Do Even Better. Here's How...(Profit Hunter)

Jun 24, 2020

Rahul is ready for a repeat of his famous 2008 Tata Motors call.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT SHARE PRICE


Jul 7, 2020 03:35 PM

TRACK WOCKHARDT

  • Track your investment in WOCKHARDT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE WOCKHARDT WITH

MARKET STATS